Tomoyuki Yamanaka
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Tomoyuki Yamanaka has a total of 103 co-authors. Here are the top co-authors by number of shared publications:
- Nobuyuki Nukina
Laboratory of Structural Neuropathology, Doshisha University Graduate School of Brain Science, Kyoto, Japan
11 shared publications Masaru Kurosawa
Department of Neuroscience for Neurodegenerative Disorders, Juntendo University Graduate School of Medicine, Tokyo, Japan
9 shared publicationsTomomi Shimogori
Laboratory for Molecular Mechanisms of Brain Development, RIKEN Center for Brain Science, Saitama, Japan
9 shared publicationsHaruko Miyazaki
Laboratory of Structural Neuropathology, Doshisha University Graduate School of Brain Science, 1-3 Tatara Miyakodani, Kyotanabe-shi, Kyoto, 610-0394, Japan
7 shared publicationsAsako Tosaki
Laboratory for Structural Neuropathology, RIKEN Brain Science Institute, Saitama, 351-0198, Japan
6 shared publicationsNobutaka Hattori
Department of Neurology, Juntendo University Graduate School of Medicine, Tokyo, Japan
6 shared publications
Latest Publications
- 7 February 2025
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 752, 151447
Phosphorylation of optineurin by TBK1 drives fragmentation of Golgi apparatus
- 7 February 2025
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 752, 151447
Phosphorylation of optineurin by TBK1 drives fragmentation of Golgi apparatus
- Open Access
- 8 January 2024
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 300 (2) , 105629
The transcription factor NF-YA is crucial for neural progenitor maintenance during brain development
- 8 January 2024
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 300 (2) , 105629
Open AccessThe transcription factor NF-YA is crucial for neural progenitor maintenance during brain development
- 15 December 2023
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 693, 149384
GPATCH4 contributes to nucleolus morphology and its dysfunction impairs cell viability
- 15 December 2023
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 693, 149384
GPATCH4 contributes to nucleolus morphology and its dysfunction impairs cell viability
- Open Access
- 1 January 2021
- Published by SAGE Publications in Contact: The Journal of Inter-Organelle Communication
- Vol. 4
Mutant VAPB: Culprit or Innocent Bystander of Amyotrophic Lateral Sclerosis?
Nearly twenty years ago a mutation in the VAPB gene, resulting in a proline to serine substitution (p.P56S), was identified as the cause of a rare, slowly progressing, familial form of the motor neuron degenerative disease Amyotrophic Lateral Sclerosis (ALS). Since then, progress in unravelling the mechanistic basis of this mutation has proceeded in parallel with research on the VAP proteins and on their role in establishing membrane contact sites between the ER and other organelles. Analysis of the literature on cellular and animal models reviewed here supports the conclusion that P56S-VAPB, which is aggregation-prone, non-functional and unstable, is expressed at levels that are insufficient to support toxic gain-of-function or dominant negative effects within motor neurons. Instead, insufficient levels of the product of the single wild-type allele appear to be required for pathological effects, and may be the main driver of the disease. In light of the multiple interactions of the VAP proteins, we address the consequences of specific VAPB depletion and highlight various affected processes that could contribute to motor neuron degeneration. In the future, distinction of specific roles of each of the two VAP paralogues should help to further elucidate the basis of p.P56S familial ALS, as well as of other more common forms of the disease.
- 1 January 2021
- Published by SAGE Publications in Contact: The Journal of Inter-Organelle Communication
- Vol. 4
Open AccessMutant VAPB: Culprit or Innocent Bystander of Amyotrophic Lateral Sclerosis?
Nearly twenty years ago a mutation in the VAPB gene, resulting in a proline to serine substitution (p.P56S), was identified as the cause of a rare, slowly progressing, familial form of the motor neuron degenerative disease Amyotrophic Lateral Sclerosis (ALS). Since then, progress in unravelling the mechanistic basis of this mutation has proceeded in parallel with research on the VAP proteins and on their role in establishing membrane contact sites between the ER and other organelles. Analysis of the literature on cellular and animal models reviewed here supports the conclusion that P56S-VAPB, which is aggregation-prone, non-functional and unstable, is expressed at levels that are insufficient to support toxic gain-of-function or dominant negative effects within motor neurons. Instead, insufficient levels of the product of the single wild-type allele appear to be required for pathological effects, and may be the main driver of the disease. In light of the multiple interactions of the VAP proteins, we address the consequences of specific VAPB depletion and highlight various affected processes that could contribute to motor neuron degeneration. In the future, distinction of specific roles of each of the two VAP paralogues should help to further elucidate the basis of p.P56S familial ALS, as well as of other more common forms of the disease.
- Open Access
- 10 December 2020
- Published by Springer Nature in Scientific Reports
- Vol. 10 (1) , 1-14
Gene expression profiling in neuronal cells identifies a different type of transcriptome modulated by NF-Y
A heterotrimeric transcription factor NF-Y is crucial for cell-cycle progression in various types of cells. In contrast, studies using NF-YA knockout mice have unveiled its essential role in endoplasmic reticulum (ER) homeostasis in neuronal cells. However, whether NF-Y modulates a different transcriptome to mediate distinct cellular functions remains obscure. Here, we knocked down NF-Y in two types of neuronal cells, neuro2a neuroblastoma cells and mouse brain striatal cells, and performed gene expression profiling. We found that down-regulated genes preferentially contained NF-Y-binding motifs in their proximal promoters, and notably enriched genes related to ER functions rather than those for cell cycle. This contrasts with the profiling data of HeLa and embryonic stem cells in which distinct down-regulation of cell cycle-related genes was observed. Clustering analysis further identified several functional clusters where populations of the down-regulated genes were highly distinct. Further analyses using chromatin immunoprecipitation and RNA-seq data revealed that the transcriptomic difference was not correlated with DNA binding of NF-Y but with splicing of NF-YA. These data suggest that neuronal cells have a different type of transcriptome in which ER-related genes are dominantly modulated by NF-Y, and imply that NF-YA splicing alteration could be involved in this cell type-specific gene modulation.
- 10 December 2020
- Published by Springer Nature in Scientific Reports
- Vol. 10 (1) , 1-14
Open AccessGene expression profiling in neuronal cells identifies a different type of transcriptome modulated by NF-Y
A heterotrimeric transcription factor NF-Y is crucial for cell-cycle progression in various types of cells. In contrast, studies using NF-YA knockout mice have unveiled its essential role in endoplasmic reticulum (ER) homeostasis in neuronal cells. However, whether NF-Y modulates a different transcriptome to mediate distinct cellular functions remains obscure. Here, we knocked down NF-Y in two types of neuronal cells, neuro2a neuroblastoma cells and mouse brain striatal cells, and performed gene expression profiling. We found that down-regulated genes preferentially contained NF-Y-binding motifs in their proximal promoters, and notably enriched genes related to ER functions rather than those for cell cycle. This contrasts with the profiling data of HeLa and embryonic stem cells in which distinct down-regulation of cell cycle-related genes was observed. Clustering analysis further identified several functional clusters where populations of the down-regulated genes were highly distinct. Further analyses using chromatin immunoprecipitation and RNA-seq data revealed that the transcriptomic difference was not correlated with DNA binding of NF-Y but with splicing of NF-YA. These data suggest that neuronal cells have a different type of transcriptome in which ER-related genes are dominantly modulated by NF-Y, and imply that NF-YA splicing alteration could be involved in this cell type-specific gene modulation.
- Open Access
- 1 July 2020
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 295 (29) , 9768-9785
FACS-array–based cell purification yields a specific transcriptome of striatal medium spiny neurons in a murine Huntington disease model
- 1 July 2020
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 295 (29) , 9768-9785
Open AccessFACS-array–based cell purification yields a specific transcriptome of striatal medium spiny neurons in a murine Huntington disease model
- Open Access
- 6 May 2020
- Published by Springer Nature in Scientific Reports
- Vol. 10 (1) , 1-16
Proteomics-Based Approach Identifies Altered ER Domain Properties by ALS-Linked VAPB Mutation
An ER transmembrane protein, vesicle-associated membrane protein-associated protein B (VAPB), binds to several organelle-resident membrane proteins to mediate ER-organelle tethering. Mutation in amyotrophic lateral sclerosis (ALS) induces protein misfolding and aggregation, leading to ER disorganization. Gain or loss of function is suggested for VAPB mutation, however comprehensive study focusing on VAPB-ER domain has yet been performed. We here conducted proteomic characterization of the ER containing VAPB and its ALS-linked P56S mutant. For this purpose, we first optimized the proteomics of different ER domains immuno-isolated from cultured cells, and identified ER sheet- and tubule-specific proteomes. By using these as references, we found that VAPB-ER proteome had intermediate ER domain properties but its tubular property was specifically decreased by its mutation. Biochemical, immunofluorescence and proximity ligation assays suggested this was mediated by delocalization of VAPB from ER tubules. The VAPB-ER proteomics further suggested reduced incorporation of multiple proteins located in different organelles, which was confirmed by proximity ligation assay. Taken together, our proteomics-based approach indicates altered ER domain properties and impaired ER-organelle tethering by VAPB mutation.
- 6 May 2020
- Published by Springer Nature in Scientific Reports
- Vol. 10 (1) , 1-16
Open AccessProteomics-Based Approach Identifies Altered ER Domain Properties by ALS-Linked VAPB Mutation
An ER transmembrane protein, vesicle-associated membrane protein-associated protein B (VAPB), binds to several organelle-resident membrane proteins to mediate ER-organelle tethering. Mutation in amyotrophic lateral sclerosis (ALS) induces protein misfolding and aggregation, leading to ER disorganization. Gain or loss of function is suggested for VAPB mutation, however comprehensive study focusing on VAPB-ER domain has yet been performed. We here conducted proteomic characterization of the ER containing VAPB and its ALS-linked P56S mutant. For this purpose, we first optimized the proteomics of different ER domains immuno-isolated from cultured cells, and identified ER sheet- and tubule-specific proteomes. By using these as references, we found that VAPB-ER proteome had intermediate ER domain properties but its tubular property was specifically decreased by its mutation. Biochemical, immunofluorescence and proximity ligation assays suggested this was mediated by delocalization of VAPB from ER tubules. The VAPB-ER proteomics further suggested reduced incorporation of multiple proteins located in different organelles, which was confirmed by proximity ligation assay. Taken together, our proteomics-based approach indicates altered ER domain properties and impaired ER-organelle tethering by VAPB mutation.
- 1 February 2020
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 522 (3) , 655-661
Preserved proteinase K-resistant core after amplification of alpha-synuclein aggregates: Implication to disease-related structural study
- 1 February 2020
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 522 (3) , 655-661
Preserved proteinase K-resistant core after amplification of alpha-synuclein aggregates: Implication to disease-related structural study
- 1 October 2019
- Published by Elsevier in Neuroscience Research
- Vol. 147, 58-63
Non-coding RNA Neat1 and Abhd11os expressions are dysregulated in medium spiny neurons of Huntington disease model mice
- 1 October 2019
- Published by Elsevier in Neuroscience Research
- Vol. 147, 58-63
Non-coding RNA Neat1 and Abhd11os expressions are dysregulated in medium spiny neurons of Huntington disease model mice
- 1 June 2019
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
- Vol. 1865 (6) , 1410-1420
Sequence- and seed-structure-dependent polymorphic fibrils of alpha-synuclein
- 1 June 2019
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
- Vol. 1865 (6) , 1410-1420
Sequence- and seed-structure-dependent polymorphic fibrils of alpha-synuclein